| Revenue growth | Revenue fell to ₹261cr from ₹280cr YoY. |
|---|---|
| Margins | EBITDA turned negative at -₹29cr due to revenue drop. |
| Order book | Order book stands at ₹55cr vs ₹6cr YoY. |
| Demand visibility | Strong pull in enterprise/government; consumer demand struggling globally. |
| Management confidence | Determined regarding transformation despite posting significant losses. |
Growth
Enterprise segment now exceeds 50% of revenue, offset by a sharp decline in consumer business due to industry headwinds.
Outlook
Management targets enterprise vertical to represent 80-90% of revenue within 2-3 years.
Risks
Consumer segment degrowth, severe IT hardware price inflation (400%), and elevated overdues from channel partners.
Earnings Call filed with NSE, NSE: QUICKHEAL. Summary written with AI assistance from the document.
Quick Heal Technologies Ltd: key numbers
- Share price
- ₹147.04
- Market cap
- ₹798.0 Cr
- Revenue (annual)
- ₹261.0 Cr
- Net profit (annual)
- ₹-10.93 Cr
- P/E (TTM)
- -74.6×Sector 22.1×
- Promoter holding
- 71.48%-0.02% QoQ
- FII holding
- 0.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Quick Heal Technologies Ltd
All →Quick Heal Technologies Management Change
Quick Heal Technologies Limited shareholders approved the re-appointment of Mr. Richard Stiennon as a Non-Executive Independent Director for a second five-year term, effective September 27, 2026.
Quick Heal Technologies Annual General Meeting
Quick Heal Technologies held its 31st Annual General Meeting on September 23, 2026, to conduct business, including the adoption of financial statements and director appointments.
Quick Heal Technologies Management Change
Quick Heal Technologies' Chief Marketing Officer, Sudhanshu Tripathi, has resigned from the company effective September 16, 2026, to pursue other professional opportunities.
Quick Heal Technologies Price Movement Clarification
Quick Heal Technologies responded to NSE's volume-spurt query, stating all Reg 30 disclosures were made. The company attributes the increase to normal market forces with no undisclosed material event.
Quick Heal Technologies Employee Stock Options
Quick Heal Technologies Limited has allotted 9,746 equity shares following the exercise of options under its ESOP Scheme 2021. The exercise prices ranged from ₹114 to ₹122.
Quick Heal Technologies Q1 FY27 Results: Net Loss of ₹5.3 Cr, Loss Narrows
Quick Heal Technologies Ltd reported revenue from operations of ₹45 Cr (-21.3% YoY) and a net loss of ₹5.3 Cr for Q1 FY27.
- Key figure
- Net loss ₹5.3 Cr